Edition:
United Kingdom

Aurobindo Pharma's Acrotech Biopharma To Buy Portfolio Of Oncology Injectable Products From Spectrum Pharmaceuticals


Thursday, 17 Jan 2019 

Jan 17 (Reuters) - Aurobindo Pharma Ltd ::UNIT ACROTECH BIOPHARMA TO ACQUIRE 7 MARKETED ONCOLOGY INJECTABLE PRODUCTS, PROPERTY, INFRASTRUCTURE FROM SPECTRUM PHARMACEUTICALS.COST OF ACQUISITION IS $160 MILLION UP-FRONT CASH PAYMENT AND UP TO $140 MILLION ON ACHIEVING MILESTONES.PORTFOLIO EXPECTED TO GENERATE REVENUE OF AROUND $100 MILLION FOR FIRST 12 MTHS AFTER DEAL COMPLETION.TRANSACTION WILL BE EPS ACCRETIVE FROM FIRST FULL YEAR OF OWNERSHIP.